TickerFactsScreenerDevelopers

Arcus Biosciences, Inc. (RCUS) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2016: -$12.94M2017: -$25.06M2018: -$43.00M2019: -$73.46M2020: $111.00M2021: -$256.00M2022: $438.00M2023: -$306.00M2024: -$170.00M2025: -$482.00M-$482.00M
2016Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$482.00M-183.5%
2024-$170.00M+44.4%
2023-$306.00M-169.9%
2022$438.00M+271.1%
2021-$256.00M-330.6%
2020$111.00M+251.1%
2019-$73.46M-70.9%
2018-$43.00M-71.6%
2017-$25.06M-93.6%
2016-$12.94M—